Product Images Briumvi

This is a drug information sheet for Briumvi (ublituximab-xiiy) injection, which is used for intravenous infusion after dilution. Each vial contains 150 mg of ublituximab-xiiy in 6 mL of solution. It must be diluted in 0.9% Sodium Chloride Injection, USP prior to use. The dosage should be followed as per prescribing information. The medication needs to be refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light, and should not be shaken or frozen. Contains one 6 mL single-dose vial. The manufacturer is TG Therapeutics, Inc., Morrisville, NC 27560.*

This is a medication with LOT number 012345, expiration date DDMMMYYYY, NDC code 73150-150-06, and dosage instructions which are provided in the prescribing information. It is a single-dose vial without preservatives and must be stored refrigerated at 2°C to 8°C (36-46°F) in its original carton to protect it from light. It contains ublituximab and is manufactured by TG Therapeutics, Inc. for intravenous infusion after dilution. The medication must not be frozen or shaken, and any unused portion must be discarded. The text also includes some illegible characters, so this may not be a complete description.*